CA2295626A1 - Nouveaux composes - Google Patents

Nouveaux composes Download PDF

Info

Publication number
CA2295626A1
CA2295626A1 CA002295626A CA2295626A CA2295626A1 CA 2295626 A1 CA2295626 A1 CA 2295626A1 CA 002295626 A CA002295626 A CA 002295626A CA 2295626 A CA2295626 A CA 2295626A CA 2295626 A1 CA2295626 A1 CA 2295626A1
Authority
CA
Canada
Prior art keywords
hydroxy
triazolo
inner salt
hydroxide
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002295626A
Other languages
English (en)
Inventor
Peter Cage
Jane Withnall
Mark Furber
David Donald
Roger Bonnert
Andrew Cooke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astra Pharmaceuticals Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9702652A external-priority patent/SE9702652D0/xx
Priority claimed from SE9703735A external-priority patent/SE9703735D0/xx
Application filed by Individual filed Critical Individual
Publication of CA2295626A1 publication Critical patent/CA2295626A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

L'invention concerne de nouveaux dérivés de triazole de la formule (I), leur utilisation comme médicaments, des compositions pharmaceutiques les contenant et leurs procédés de préparation.
CA002295626A 1997-07-09 1998-06-29 Nouveaux composes Abandoned CA2295626A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE9702652-0 1997-07-09
SE9702652A SE9702652D0 (sv) 1997-07-09 1997-07-09 Novel compounds
SE9703735A SE9703735D0 (sv) 1997-10-14 1997-10-14 Novel compounds
SE9703735-2 1997-10-14
PCT/SE1998/001286 WO1999002528A1 (fr) 1997-07-09 1998-06-29 Nouveaux composes

Publications (1)

Publication Number Publication Date
CA2295626A1 true CA2295626A1 (fr) 1999-01-21

Family

ID=26663033

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002295626A Abandoned CA2295626A1 (fr) 1997-07-09 1998-06-29 Nouveaux composes

Country Status (5)

Country Link
EP (1) EP1000060A1 (fr)
JP (1) JP2001509509A (fr)
AU (1) AU8362498A (fr)
CA (1) CA2295626A1 (fr)
WO (1) WO1999002528A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2827599A1 (fr) * 2001-07-20 2003-01-24 Neuro3D Composes derives de quinoleine et quinoxaline,preparation et utilisations
DE10229762A1 (de) * 2002-07-03 2004-01-22 Aventis Pharma Deutschland Gmbh Pyrazoloisoquinolinenderivaten zur Inhibierung von NFkappaB-induzierende Kinase
CN106432067B (zh) * 2016-09-18 2019-04-19 北京天弘天达医药科技有限公司 一种3-吡啶磺酰氯的绿色化学合成方法
KR102201768B1 (ko) * 2019-02-28 2021-01-12 주식회사 엘마이토테라퓨틱스 벤조인다졸론 화합물 및 그 용도
CN114195792B (zh) * 2021-12-03 2023-01-17 常州大学 一种1,2,3-三氮唑喹喔啉酮衍生物的合成方法

Also Published As

Publication number Publication date
WO1999002528A1 (fr) 1999-01-21
EP1000060A1 (fr) 2000-05-17
AU8362498A (en) 1999-02-08
JP2001509509A (ja) 2001-07-24

Similar Documents

Publication Publication Date Title
AU686115B2 (en) Imidazo (I,2-a) pyridine derivatives as bradykinin antagonists, pharmaceuticals and processes for their preparation
TWI541241B (zh) 作為呼吸道融合病毒抗病毒劑之咪唑并吡啶類
AU719392B2 (en) Nitrogen-containing heterocyclic compounds
AU712141B2 (en) Pharmaceutically useful compounds
KR100264114B1 (ko) 인돌-2-카르복실산유도체
AU747506B2 (en) Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors
FI109692B (fi) Menetelmä terapeuttisesti käyttökelpoisten mahdollisesti substituoitujen 6,8-kinoliinien valmistamiseksi
EP3480199B1 (fr) Dérivé d'imidazopyridinamine phényle et son utilisation
AU2002343110B2 (en) Imidazopyridines, pyrimidines and triazines for enhancing cognition as GABA-A alpha 5 receptor subtype ligands
US4576952A (en) Pyrazolopyridine derivatives and their use as anti-inflammatory and/or anti-allergic agents
CZ292311B6 (cs) Pyridazinové deriváty, způsob jejich výroby a farmaceutické prostředky, které je obsahují
CZ20033034A3 (en) Novel 4-anilinoquinoline-3-carboxamides
EP4071144A1 (fr) Composés hétérocycliques substitués par des groupements amides utiles en tant que modulateurs d'il-12, il-23 et/ou de réponses ifn alpha
HU210873A9 (en) Optionally substituted pyrido/2,3-d/pyrimidine-2,4(1h,3h)-diones and pyrido/2,3-d/ pyrimidine-2(1h,3h)-ones
NO178697B (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyrazolopyridin-forbindelser
AU744540B2 (en) 6,7-asymmetrically disubstituted quinoxalinecarboxylic acid derivatives, addition salts thereof, and processes for the preparation of both
NO310355B1 (no) Tetrahydrokinoliner som NMDA-antagonister, anvendelse derav, fremgangsmåte for fremstilling derav og farmasöytisk preparat
JPH0499768A (ja) ４―（４―フェニルピリジン―２―イル）ピペラジン―１―オキシド誘導体
Tang et al. Design and synthesis of novel quinoline derivatives bearing oxadiazole, isoxazoline, triazolothiadiazole, triazolothiadiazine, and piperazine moieties
NZ208180A (en) Dihydrobenzopyrrolobenzodiazepines and pharmaceutical compositions
Guang‐Fu et al. Syntheses and properties of new herbicidal 2‐arylthio‐l, 2, 4‐triazolo [l, 5‐a] pyrimidine derivatives
CA2295626A1 (fr) Nouveaux composes
JPS6110584A (ja) イミダゾイソキノリン化合物およびその製造方法
NZ207581A (en) (1h-tetrazol-5-yl)-2(1h)-quinolinone and(1h-tetrazol-5-yl)2(1h)-naphthyridinone derivatives and method for their preparation
NO140012B (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive derivater av naftyridin

Legal Events

Date Code Title Description
FZDE Dead